Agios Pharma (AGIO) Tops Q1 EPS by 23c

Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.55), $0.23 better than the analyst estimate of ($1.78). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $9.97 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Avis Budget Group reaches $650M settlement with Pentwater Capital
• Japan's Katayama, Us Treasury's Bessent Hold Online Talks, Source Says - Reuters